Regulatory tracker: Pfizer's Vyndaqel secures NICE nod 3 years after initial rejection
Welcome to 2024's regulatory tracker for Fierce Pharma. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not make the bar for …